Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered...

Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and
Special Court-Ordered Meeting of Shareholders

ARDEE, Ireland, June 26 /PRNewswire-FirstCall/ -- Warner Chilcott Limited
announced today that it will hold its 2009 Annual General Meeting of
Shareholders (the "Annual Meeting") and a Special Court-Ordered Meeting of
Shareholders (the "Special Meeting") on August 5, 2009. At the Special
Meeting, the Company's shareholders will be asked to vote in favor of certain
matters related to the proposed redomestication of the Company from Bermuda to
Ireland. Subject to shareholder approval and the approval of the Supreme
Court of Bermuda, the redomestication will result in the creation of a newly
formed public holding company organized in, and a tax resident of, Ireland.
The new company, Warner Chilcott plc, will replace Warner Chilcott Limited as
the ultimate public holding company. The Annual Meeting will be held at 2:00
p.m. (local time). The Special Meeting will be held immediately following the
conclusion of the Annual Meeting. Both meetings will take place at The K
Club, Straffan, Co Kildare, Ireland.

A definitive proxy statement for the Annual Meeting and the Special Meeting
has been filed with the Securities and Exchange Commission (the "SEC") and is
expected to be mailed on or about June 29, 2009 to all shareholders of the
Company as of June 19, 2009, the record date for both the Annual Meeting and
the Special Meeting. During the meetings, shareholders will vote on the
proposals listed in the definitive proxy statement.

The Company does not expect the proposed redomestication will have any
material impact on its financial results. The Company will, upon completion
of the proposed redomestication, continue to be subject to SEC reporting
requirements, and the Company's shares will continue to be listed on the
Nasdaq under the symbol "WCRX". Additional information on the proposed
redomestication, including associated benefits and risks, is contained in the
definitive proxy statement.

Important Information for Shareholders
This communication is for informational purposes only and is not a substitute
for any proxy statement and related documents that the Company has filed and
may file with the SEC. The Company has filed with the SEC a definitive proxy
statement and intends to mail the definitive proxy statement on or about June
29, 2009 to all shareholders of Warner Chilcott as of June 19, 2009.
Shareholders are urged to read the definitive proxy statement in its entirety
because it contains important information about the proposed redomestication.
The definitive proxy statement is, and other documents filed or to be filed by
the Company with the SEC are, or will be, available free of charge at the
SEC's web site (www.sec.gov) and at the Company's web site (www.wcrx.com).

The Company and its directors and executive officers and other persons may be
deemed participants in the solicitation of proxies from the Company's
stockholders in connection with the proposed redomestication. Information
regarding the persons who may, under the rules of the SEC, be deemed
participants in the solicitation of the Company's shareholders in connection
with the proposed redomestication is set forth in the definitive proxy
statement.

The Company
Warner Chilcott is a leading specialty pharmaceutical company currently
focused on the women's healthcare and dermatology segments of the U.S.
pharmaceuticals market. The Company is a fully integrated company with
internal resources dedicated to the development, manufacturing and promotion
of its products. WCRX-G

SOURCE Warner Chilcott Limited

Rochelle Fuhrmann, Investor Relations of Warner Chilcott, +1-973-442-3281, or
rfuhrmann@wcrx.com